[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Dermatological Therapeutics Market Size, Trends, Analysis, and Outlook By Application (Alopecia, Herpes, Psoriasis, Rosacea, Atopic Dermatitis, Others), By Drug Class (Anti-infectives, Corticosteroids, Anti-acne, Calcineurin Inhibitors, Retinoids, Others), by Country, Segment, and Companies, 2024-2032

April 2024 | 205 pages | ID: D388C578DB86EN
VPAResearch

US$ 3,980.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global Dermatological Therapeutics market size is poised to register 10.2% growth from 2024 to 2032, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Dermatological Therapeutics market across By Application (Alopecia, Herpes, Psoriasis, Rosacea, Atopic Dermatitis, Others), By Drug Class (Anti-infectives, Corticosteroids, Anti-acne, Calcineurin Inhibitors, Retinoids, Others)

With the increasing prevalence of skin disorders such as psoriasis, atopic dermatitis, and melanoma and the growing demand for effective and targeted treatments that address underlying disease mechanisms and symptomatology, there is a rising adoption of dermatological therapeutics that offer novel therapeutic modalities and personalized treatment approaches, improving clinical outcomes and quality of life for patients with dermatological conditions. Market growth is driven by factors such as expanding research and development efforts, rising healthcare expenditure on dermatology drugs, and advancements in biologic agents and small molecule inhibitors for inflammatory and neoplastic skin diseases. Additionally, the expanding applications of dermatological therapeutics in systemic and topical treatments, phototherapy, and immunomodulatory interventions, as well as the development of combination regimens and precision medicine strategies based on genetic and immunological profiling, contribute to market expansion. Further, the emphasis on patient-centered care, shared decision-making, and long-term treatment adherence in dermatology practice, along with efforts to optimize drug safety profiles and mitigate treatment-related adverse events through pharmacovigilance and drug monitoring programs, is expected to further accelerate market growth in the coming years.

Dermatological Therapeutics Market Drivers, Trends, Opportunities, and Growth Opportunities

This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Dermatological Therapeutics market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Dermatological Therapeutics survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Dermatological Therapeutics industry.

Key market trends defining the global Dermatological Therapeutics demand in 2024 and Beyond

The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.

Dermatological Therapeutics Market Segmentation- Industry Share, Market Size, and Outlook to 2032

The Dermatological Therapeutics industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Dermatological Therapeutics companies scaling up production in these sub-segments with a focus on expanding into emerging countries.

Key strategies adopted by companies within the Dermatological Therapeutics industry

Leading Dermatological Therapeutics companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Dermatological Therapeutics companies.

Dermatological Therapeutics Market Study- Strategic Analysis Review

The Dermatological Therapeutics market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
  • Industry Dynamics: Porter's Five Forces analysis to understand bargaining power, competitive rivalry, and threats that impact long-term strategy formulation.
  • Strategic Insights: Provides valuable perspectives on key players and their approaches based on comprehensive strategy analysis.
  • Internal Strengths and Weaknesses: Develop targeted strategies to leverage strengths, address weaknesses, and capitalize on market opportunities.
  • Future Possibilities: Prepare for diverse outcomes with in-depth scenario analysis. Explore potential market disruptions, technology advancements, and economic changes.
Dermatological Therapeutics Market Size Outlook- Historic and Forecast Revenue in Three Cases

The Dermatological Therapeutics industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2032 in three case scenarios- low case, reference case, and high case scenarios.

Dermatological Therapeutics Country Analysis and Revenue Outlook to 2032

The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2032. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2032.

North America Dermatological Therapeutics Market Size Outlook- Companies plan for focused investments in a changing environment

The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong healthcare infrastructure. Leading companies focus on new product launches in the changing environment. The US healthcare expenditure is expected to grow to $4.8 trillion in 2024 (around 3.7% growth in 2024), potentially driving demand for various Dermatological Therapeutics market segments. Similarly, Strong market demand is encouraging Canadian Dermatological Therapeutics companies to invest in niche segments. Further, as Mexico continues to strengthen its relations and invest in technological advancements, the Mexico Dermatological Therapeutics market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.

Europe Dermatological Therapeutics Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities

The German industry remains the major market for companies in the European Dermatological Therapeutics industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of vendors in identifying and leveraging new growth prospects positions the European Dermatological Therapeutics market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.

Asia Pacific Dermatological Therapeutics Market Size Outlook- an attractive hub for opportunities for both local and global companies

The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Dermatological Therapeutics in Asia Pacific. In particular, China, India, and South East Asian Dermatological Therapeutics markets present a compelling outlook for 2032, acting as a magnet for both domestic and multinational vendors seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major countries in the APAC region.

Latin America Dermatological Therapeutics Market Size Outlook- Continued urbanization and rising income levels

Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.

Middle East and Africa Dermatological Therapeutics Market Size Outlook- continues its upward trajectory across segments

Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Dermatological Therapeutics market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Dermatological Therapeutics.

Dermatological Therapeutics Market Company Profiles

The global Dermatological Therapeutics market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are Abbvie Inc, Aclaris Therapeutics Inc, Almirall SA, Amgen Inc, Aurobindo Pharma Ltd, Bausch Health Companies Inc, Bristol-Myers Squibb Company, Eli Lilly and Company, Galderma SA, GlaxoSmithKline PLC, Johnson & Johnson, LEO Pharma AS, Novartis AG, Pfizer Inc, Sun Pharmaceuticals Ltd.

Recent Dermatological Therapeutics Market Developments

The global Dermatological Therapeutics market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.

Dermatological Therapeutics Market Report Scope

Parameters: Revenue, Volume Price

Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2032 (Forecast Period)

Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)

Qualitative Analysis
  • Pricing Analysis
  • Value Chain Analysis
  • SWOT Profile
  • Market Dynamics- Trends, Drivers, Challenges
  • Porter’s Five Forces Analysis
  • Macroeconomic Impact Analysis
  • Case Scenarios- Low, Base, High
Market Segmentation:

By Application

Alopecia

Herpes

Psoriasis

Rosacea

Atopic Dermatitis

Others

By Drug Class

Anti-infectives

Corticosteroids

Anti-acne

Calcineurin Inhibitors

Retinoids

Others

Geographical Segmentation:
  • North America (3 markets)
  • Europe (6 markets)
  • Asia Pacific (6 markets)
  • Latin America (3 markets)
  • Middle East Africa (5 markets)
Companies

Abbvie Inc

Aclaris Therapeutics Inc

Almirall SA

Amgen Inc

Aurobindo Pharma Ltd

Bausch Health Companies Inc

Bristol-Myers Squibb Company

Eli Lilly and Company

Galderma SA

GlaxoSmithKline PLC

Johnson & Johnson

LEO Pharma AS

Novartis AG

Pfizer Inc

Sun Pharmaceuticals Ltd

Formats Available: Excel, PDF, and PPT
1. EXECUTIVE SUMMARY

1.1 Dermatological Therapeutics Market Overview and Key Findings, 2024
1.2 Dermatological Therapeutics Market Size and Growth Outlook, 2021- 2030
1.3 Dermatological Therapeutics Market Growth Opportunities to 2030
1.4 Key Dermatological Therapeutics Market Trends and Challenges
  1.4.1 Dermatological Therapeutics Market Drivers and Trends
  1.4.2 Dermatological Therapeutics Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Dermatological Therapeutics Companies

2. DERMATOLOGICAL THERAPEUTICS MARKET SIZE OUTLOOK TO 2030

2.1 Dermatological Therapeutics Market Size Outlook, USD Million, 2021- 2030
2.2 Dermatological Therapeutics Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024

3. DERMATOLOGICAL THERAPEUTICS MARKET- STRATEGIC ANALYSIS REVIEW

3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis

4. DERMATOLOGICAL THERAPEUTICS MARKET SEGMENTATION ANALYSIS AND OUTLOOK

4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Application
Alopecia
Herpes
Psoriasis
Rosacea
Atopic Dermatitis
Others
By Drug Class
Anti-infectives
Corticosteroids
Anti-acne
Calcineurin Inhibitors
Retinoids
Others
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030

5. REGION-WISE MARKET OUTLOOK TO 2030

5.1 Key Findings for Asia Pacific Dermatological Therapeutics Market, 2025
5.2 Asia Pacific Dermatological Therapeutics Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Dermatological Therapeutics Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Dermatological Therapeutics Market, 2025
5.5 Europe Dermatological Therapeutics Market Size Outlook by Type, 2021- 2030
5.6 Europe Dermatological Therapeutics Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Dermatological Therapeutics Market, 2025
5.8 North America Dermatological Therapeutics Market Size Outlook by Type, 2021- 2030
5.9 North America Dermatological Therapeutics Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Dermatological Therapeutics Market, 2025
5.11 South America Pacific Dermatological Therapeutics Market Size Outlook by Type, 2021- 2030
5.12 South America Dermatological Therapeutics Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Dermatological Therapeutics Market, 2025
5.14 Middle East Africa Dermatological Therapeutics Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Dermatological Therapeutics Market Size Outlook by Application, 2021- 2030

6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030

6.1 US Dermatological Therapeutics Market Size Outlook and Revenue Growth Forecasts
6.2 US Dermatological Therapeutics Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Dermatological Therapeutics Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Dermatological Therapeutics Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Dermatological Therapeutics Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Dermatological Therapeutics Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Dermatological Therapeutics Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Dermatological Therapeutics Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Dermatological Therapeutics Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Dermatological Therapeutics Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Dermatological Therapeutics Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Dermatological Therapeutics Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Dermatological Therapeutics Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Dermatological Therapeutics Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Dermatological Therapeutics Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Dermatological Therapeutics Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Dermatological Therapeutics Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Dermatological Therapeutics Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Dermatological Therapeutics Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Dermatological Therapeutics Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Dermatological Therapeutics Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Dermatological Therapeutics Industry Drivers and Opportunities

7. DERMATOLOGICAL THERAPEUTICS MARKET OUTLOOK ACROSS SCENARIOS

7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case

8. DERMATOLOGICAL THERAPEUTICS COMPANY PROFILES

8.1 Profiles of Leading Dermatological Therapeutics Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
Abbvie Inc
Aclaris Therapeutics Inc
Almirall SA
Amgen Inc
Aurobindo Pharma Ltd
Bausch Health Companies Inc
Bristol-Myers Squibb Company
Eli Lilly and Company
Galderma SA
GlaxoSmithKline PLC
Johnson & Johnson
LEO Pharma AS
Novartis AG
Pfizer Inc
Sun Pharmaceuticals Ltd.

9. APPENDIX

9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information


More Publications